Delving into the Latest Updates on Boehringer Ingelheim BV with Synapse

Overview

AbstractThis study aims to understand healthcare professionals’ thoughts and motivations about optimal management and treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). We conducted a DELPHI survey through an online questionnaire distributed to 220 panellists from six European countries and a discrete choice experiment to describe the relationship between selected clinical criteria and the initial COPD treatment of choice. 127 panellists (general practitioners [GPs] and pulmonologists) completed the survey. Despite the familiarity and use (89.8%) of the GOLD classification for initial treatment selection, a frequent use of LAMA/LABA/ICS was noted. In fact, panellists agreed that inhaled corticosteroids (ICS) are over-prescribed in the primary care setting. Our study showed that GPs felt less confident than pulmonologists with ICS withdrawal. This mismatch observed between best practice and behaviour indicates the need to increase awareness and efforts to improve the adherence to guidelines in clinical practice.

100 Deals associated with Boehringer Ingelheim BV

Login to view more data

100 Translational Medicine associated with Boehringer Ingelheim BV

Login to view more data